期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | International Journal of Clinical and Experimental Pathology (According to the latest JCR data, this journal is not indexed in the JCR.) LetPub Score 3.4
50 ratings
Rate
Reputation 1.5 Influence 3.7 Speed 9.6 | ||||||||||||||||
期刊簡稱 | INT J CLIN EXP PATHO | ||||||||||||||||
ISSN | 1936-2625 | ||||||||||||||||
h-index | 43 | ||||||||||||||||
CiteScore | N.A. | ||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.ijcep.com/ | ||||||||||||||||
在線稿件提交 | http://www.e-century.us/submission/user_login.php?URL=app.php?j=ijcep | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | |||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 2008 | ||||||||||||||||
每年文章數 | 42每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||
索引 (SCI or SCIE) | |||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1936-2625%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[International Journal of Clinical and Experimental Pathology] 的評論 | 撰寫評論 |
作者: 京城艳娇 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-28 11:56:01 評論於 Hello, I am in the same situation. How long does it take to receive the payment reminder email?(0) 讚! | 京城艳娇 |
作者: 太山淑怡 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-19 18:14:49 評論於 I made a mistake, this year both Esci and Ahci also have impact factors. This is not the impact factor of Sci(0) 讚! | 太山淑怡 |
作者: 一只范明呀 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-11 13:45:00 評論於 Cow(0) 讚! | 一只范明呀 |
作者: 太山淑怡 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-28 22:18:27 評論於 IF: 1.4, stood up again!(0) 讚! | 太山淑怡 |
作者: 是皓轩吖 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-28 10:48:58 評論於 It's too difficult(0) 讚! | 是皓轩吖 |
作者: 长安鸿熙 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-25 13:14:22 評論於 It's so difficult(0) 讚! | 长安鸿熙 |
作者: 长拳梓玥 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-08 19:01:47 評論於 Hahaha(0) 讚! | 长拳梓玥 |
作者: 华清静夏 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-20 09:25:38 評論於 It has been a week since I submitted the manuscript. It is currently under review, but I only just realized that I have not received a confirmation email for the submission. Why is that?(0) 讚! | 华清静夏 |
作者: 擒龙咸英 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-08 13:05:00 評論於 SCI has been removed, of course it's no longer there(0) 讚! | 擒龙咸英 |
作者: 维尔娜菲茨杰拉德 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:01:51 評論於 I love traveling to different countries and immersing myself in new cultures. It is a great way to broaden my horizons and gain a better understanding of the world(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:28:43 評論於 Number of articles published each year, whether or not only invited submissions are accepted (some authors have chosen such journals and are unable to submit articles), and requirements for publishing on specific topics(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Belle Raymond 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-29 22:08:46 評論於 Research Focus: Tumor Experience Sharing: The 2021 "International Journal Alert List (Trial)" has been officially released. International Journal of Clinical and Experimental Pathology (IJCEP) is no longer on this alert list. For more details, please refer to https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA(0) 讚! | Belle Raymond |
作者: 上清雨真 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:04:09 評論於 Should we choose both traditional journals and newly published journals?(0) 讚! | 上清雨真 |
作者: 平原文波 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 08:17:07 評論於 What else should be considered when selecting articles for publication, in addition to content and quality?(0) 讚! | 平原文波 |
作者: 天际曦晨 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-15 08:44:01 評論於 It used to be impossible to find it on PubMed, but can it be searched on PubMed now?(0) 讚! | 天际曦晨 |
作者: 玉俊三岁啦 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-07 15:28:38 評論於 Please translate the following paragraph into English and Japanese, and title them with ":" and ":"(0) 讚! | 玉俊三岁啦 |
作者: 天山羽沫 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-13 08:19:20 評論於 What time is it now?(0) 讚! | 天山羽沫 |
作者: 削月飞文 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-06 08:10:35 評論於 Physical science newspaper(0) 讚! | 削月飞文 |
作者: Noel Zangwill 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-04 08:38:42 評論於 Thank you(0) 讚! | Noel Zangwill |
作者: 杨家兴敏 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-03 14:22:32 評論於 Review speed: 1.0 | Submission success rate: 95.0 | Layout fee: 13000.0 Experience sharing: Ah(0) 讚! | 杨家兴敏 |
作者: 慈悲妙意 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-10 13:45:57 評論於 Where can I watch the game that got kicked off?(0) 讚! | 慈悲妙意 |
作者: 魔都梦晨 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-07 14:30:27 評論於 Correct(0) 讚! | 魔都梦晨 |
作者: swcyo 領域: 医学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2021-03-03 12:31:27 評論於 There is an even more rubbish IJCEM.(0) 讚! | swcyo |
作者: swcyo 領域: 医学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2021-03-03 12:30:27 評論於 Currently, it has been kicked out of SCI and whether the content is good or not, it only looks at plagiarism checking. If it passes, it can be admitted.(2) 讚! | swcyo |
作者: 气甲胜换 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-02-25 12:07:28 評論於 I've been kicked out, better hurry up**(0) 讚! | 气甲胜换 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us